Sökning: WFRF:(Lonn Eva)
> (2015-2019) >
Blood-Pressure Lowe...
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
-
- Lonn, Eva M. (författare)
- McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.;McMaster Univ, Dept Med, Hamilton, ON, Canada.
-
- Bosch, Jackie (författare)
- McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.;McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.
-
- Lopez-Jaramillo, Patricio (författare)
- Univ Santander, Fdn Oftalmol Santander, Bucaramanga, Colombia.;Univ Santander, Sch Med, Inst Masira, Bucaramanga, Colombia.
-
visa fler...
-
- Zhu, Jun (författare)
- Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China.;Peking Union Med Coll, Beijing 100021, Peoples R China.
-
- Liu, Lisheng (författare)
- Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China.;Peking Union Med Coll, Beijing 100021, Peoples R China.
-
- Pais, Prem (författare)
- St Johns Res Inst, Bangalore, Karnataka, India.
-
- Diaz, Rafael (författare)
- Inst Cardiovasc Rosario, Rosario, Santa Fe, Argentina.
-
- Xavier, Denis (författare)
- St Johns Res Inst, Bangalore, Karnataka, India.;St Johns Med Coll, Bangalore, Karnataka, India.
-
- Sliwa, Karen (författare)
- Univ Cape Town, Soweto Cardiovasc Res Grp, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa.
-
- Dans, Antonio (författare)
- Univ Philippines, Coll Med, Manila, Philippines.
-
- Avezum, Alvaro (författare)
- Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil.
-
- Piegas, Leopoldo S. (författare)
- HCor Heart Hosp, Sao Paulo, Brazil.
-
- Keltai, Katalin (författare)
- Semmelweis Univ, Hungarian Inst Cardiol, H-1085 Budapest, Hungary.
-
- Keltai, Matyas (författare)
- Semmelweis Univ, Hungarian Inst Cardiol, H-1085 Budapest, Hungary.
-
- Chazova, Irina (författare)
- Inst Clin Cardiol, Russian Cardiol Res Complex, Moscow, Russia.
-
- Peters, Ron J. G. (författare)
- Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
-
- Held, Claes (författare)
- Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)
-
- Yusoff, Khalid (författare)
- Univ Teknol Majlis Amansh Rakyat, Selayang, Malaysia.;Univ Coll Sedaya Int Univ, Kuala Lumpur, Malaysia.
-
- Lewis, Basil S. (författare)
- Technion Israel Inst Technol, Lady Davis Carmel Med Ctr, Ruth & Bruce Rappaport Sch Med, Haifa, Israel.
-
- Jansky, Petr (författare)
- Univ Hosp Motol, Prague, Czech Republic.
-
- Parkhomenko, Alexander (författare)
- Inst Cardiol, Kiev, Ukraine.
-
- Khunti, Kamlesh (författare)
- Univ Leicester, Diabet Res Ctr, Leicester, Leics, England.
-
- Toff, William D. (författare)
- Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.;Glenfield Hosp, Leicester Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England.
-
- Reid, Christopher M. (författare)
- Monash Univ, Monash Ctr Cardiovasc Res & Educ Therapeut, Primary Care Diabet & Vasc Med, Melbourne, Vic 3004, Australia.;Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia.
-
- Varigos, John (författare)
- Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.
-
- Leiter, Lawrence A. (författare)
- Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.;Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.
-
- Molina, Dora I. (författare)
- Univ Caldas, Manizales, Colombia.;Inst Prestadora Salud Internistas Caldas, Manizales, Colombia.
-
- McKelvie, Robert (författare)
- McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.;McMaster Univ, Dept Med, Hamilton, ON, Canada.
-
- Pogue, Janice (författare)
- McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.;McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
-
- Wilkinson, Joanne (författare)
- McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.
-
- Jung, Hyejung (författare)
- McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.
-
- Dagenais, Gilles (författare)
- Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.
-
- Yusuf, Salim (författare)
- McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.;McMaster Univ, Dept Med, Hamilton, ON, Canada.
-
visa färre...
-
McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada;McMaster Univ, Dept Med, Hamilton, ON, Canada. McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.;McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada. (creator_code:org_t)
- 2016
- 2016
- Engelska.
-
Ingår i: New England Journal of Medicine. - 0028-4793 .- 1533-4406. ; 374:21, s. 2009-2020
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND Antihypertensive therapy reduces the risk of cardiovascular events among high-risk persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its role in persons at intermediate risk and with lower blood pressure is unclear.METHODS In one comparison from a 2-by-2 factorial trial, we randomly assigned 12,705 participants at intermediate risk who did not have cardiovascular disease to receive either candesartan at a dose of 16 mg per day plus hydrochlorothiazide at a dose of 12.5 mg per day or placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke; the second coprimary outcome additionally included resuscitated cardiac arrest, heart failure, and revascularization. The median follow-up was 5.6 years.RESULTS The mean blood pressure of the participants at baseline was 138.1/81.9 mm Hg; the decrease in blood pressure was 6.0/3.0 mm Hg greater in the active-treatment group than in the placebo group. The first coprimary outcome occurred in 260 participants (4.1%) in the active-treatment group and in 279 (4.4%) in the placebo group (hazard ratio, 0.93; 95% confidence interval [CI], 0.79 to 1.10; P = 0.40); the second coprimary outcome occurred in 312 participants (4.9%) and 328 participants (5.2%), respectively (hazard ratio, 0.95; 95% CI, 0.81 to 1.11; P = 0.51). In one of the three prespecified hypothesis-based subgroups, participants in the subgroup for the upper third of systolic blood pressure (>143.5 mm Hg) who were in the active-treatment group had significantly lower rates of the first and second coprimary outcomes than those in the placebo group; effects were neutral in the middle and lower thirds (P = 0.02 and P = 0.009, respectively, for trend in the two outcomes).CONCLUSIONS Therapy with candesartan at a dose of 16 mg per day plus hydrochlorothiazide at a dose of 12.5 mg per day was not associated with a lower rate of major cardiovascular events than placebo among persons at intermediate risk who did not have cardiovascular disease. ( ClinicalTrials. gov number, NCT00468923.)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Lonn, Eva M.
-
Bosch, Jackie
-
Lopez-Jaramillo, ...
-
Zhu, Jun
-
Liu, Lisheng
-
Pais, Prem
-
visa fler...
-
Diaz, Rafael
-
Xavier, Denis
-
Sliwa, Karen
-
Dans, Antonio
-
Avezum, Alvaro
-
Piegas, Leopoldo ...
-
Keltai, Katalin
-
Keltai, Matyas
-
Chazova, Irina
-
Peters, Ron J. G ...
-
Held, Claes
-
Yusoff, Khalid
-
Lewis, Basil S.
-
Jansky, Petr
-
Parkhomenko, Ale ...
-
Khunti, Kamlesh
-
Toff, William D.
-
Reid, Christophe ...
-
Varigos, John
-
Leiter, Lawrence ...
-
Molina, Dora I.
-
McKelvie, Robert
-
Pogue, Janice
-
Wilkinson, Joann ...
-
Jung, Hyejung
-
Dagenais, Gilles
-
Yusuf, Salim
-
visa färre...
- Artiklar i publikationen
-
New England Jour ...
- Av lärosätet
-
Uppsala universitet